Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.

Ye J, Kawaguchi M, Haruyama Y, Kanemaru A, Fukushima T, Yamamoto K, Lin CY, Kataoka H.

Cancer Sci. 2014 Jan;105(1):44-51. doi: 10.1111/cas.12306. Epub 2013 Nov 25.

PMID:
24147538
[PubMed - indexed for MEDLINE]
2.

Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.

Cheng H, Fukushima T, Takahashi N, Tanaka H, Kataoka H.

Cancer Res. 2009 Mar 1;69(5):1828-35. doi: 10.1158/0008-5472.CAN-08-3728. Epub 2009 Feb 17.

PMID:
19223533
[PubMed - indexed for MEDLINE]
Free Article
3.

Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells.

Fukushima T, Kawaguchi M, Yamasaki M, Tanaka H, Yorita K, Kataoka H.

Cancer Sci. 2011 Feb;102(2):407-13. doi: 10.1111/j.1349-7006.2010.01808.x. Epub 2010 Dec 20.

PMID:
21166957
[PubMed - indexed for MEDLINE]
4.

Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.

Baba T, Kawaguchi M, Fukushima T, Sato Y, Orikawa H, Yorita K, Tanaka H, Lin CY, Sakoda S, Kataoka H.

J Pathol. 2012 Oct;228(2):181-92. doi: 10.1002/path.3993. Epub 2012 Apr 18.

PMID:
22262311
[PubMed - indexed for MEDLINE]
5.

Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.

Parr C, Jiang WG.

Int J Cancer. 2006 Sep 1;119(5):1176-83.

PMID:
16557597
[PubMed - indexed for MEDLINE]
6.

Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.

Kohama K, Kawaguchi M, Fukushima T, Lin CY, Kataoka H.

Hum Cell. 2012 Dec;25(4):100-10. doi: 10.1007/s13577-012-0055-2. Epub 2012 Dec 18.

PMID:
23248048
[PubMed - indexed for MEDLINE]
7.

Imbalanced matriptase pericellular proteolysis contributes to the pathogenesis of malignant B-cell lymphomas.

Chou FP, Chen YW, Zhao XF, Xu-Monette ZY, Young KH, Gartenhaus RB, Wang JK, Kataoka H, Zuo AH, Barndt RJ, Johnson M, Lin CY.

Am J Pathol. 2013 Oct;183(4):1306-17. doi: 10.1016/j.ajpath.2013.06.024.

PMID:
24070417
[PubMed - indexed for MEDLINE]
8.

High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice.

Kitamura N, Iwamura T, Taniguchi S, Yamanari H, Kawano MA, Hollingsworth K, Setoguchi T.

Clin Exp Metastasis. 2000;18(7):561-71.

PMID:
11688961
[PubMed - indexed for MEDLINE]
9.

Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.

Szabo R, Hobson JP, List K, Molinolo A, Lin CY, Bugge TH.

J Biol Chem. 2008 Oct 24;283(43):29495-504. doi: 10.1074/jbc.M801970200. Epub 2008 Aug 19.

PMID:
18713750
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.

Domoto T, Takino T, Guo L, Sato H.

Cancer Sci. 2012 Mar;103(3):448-54. doi: 10.1111/j.1349-7006.2011.02162.x. Epub 2011 Dec 28.

PMID:
22118498
[PubMed - indexed for MEDLINE]
11.
12.

Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.

Larsen BR, Steffensen SD, Nielsen NV, Friis S, Godiksen S, Bornholdt J, Soendergaard C, Nonboe AW, Andersen MN, Poulsen SS, Szabo R, Bugge TH, Lin CY, Skovbjerg H, Jensen JK, Vogel LK.

Exp Cell Res. 2013 Apr 1;319(6):918-29. doi: 10.1016/j.yexcr.2013.01.008. Epub 2013 Jan 16.

PMID:
23333561
[PubMed - indexed for MEDLINE]
13.

Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.

Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.

Cancer Res. 2005 Sep 1;65(17):7775-81.

PMID:
16140945
[PubMed - indexed for MEDLINE]
Free Article
14.

Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.

Parr C, Jiang WG.

Int J Oncol. 2001 Oct;19(4):857-63.

PMID:
11562767
[PubMed - indexed for MEDLINE]
15.

Antithrombin regulates matriptase activity involved in plasmin generation, syndecan shedding, and HGF activation in keratinocytes.

Chen YW, Xu Z, Baksh AN, Wang JK, Chen CY, Swanson R, Olson ST, Kataoka H, Johnson MD, Lin CY.

PLoS One. 2013 May 13;8(5):e62826. doi: 10.1371/journal.pone.0062826. Print 2013.

PMID:
23675430
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Role of matriptase and proteinase-activated receptor-2 in nonmelanoma skin cancer.

Bocheva G, Rattenholl A, Kempkes C, Goerge T, Lin CY, D'Andrea MR, Ständer S, Steinhoff M.

J Invest Dermatol. 2009 Jul;129(7):1816-23. doi: 10.1038/jid.2008.449. Epub 2009 Feb 26.

PMID:
19242518
[PubMed - indexed for MEDLINE]
Free Article
17.

Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.

Wang JK, Lee MS, Tseng IC, Chou FP, Chen YW, Fulton A, Lee HS, Chen CJ, Johnson MD, Lin CY.

Am J Physiol Cell Physiol. 2009 Aug;297(2):C459-70. doi: 10.1152/ajpcell.00201.2009. Epub 2009 Jun 17.

PMID:
19535514
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.

Zhao B, Yuan C, Li R, Qu D, Huang M, Ngo JC.

J Biol Chem. 2013 Apr 19;288(16):11155-64. doi: 10.1074/jbc.M113.454611. Epub 2013 Feb 26.

PMID:
23443661
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.

Oberst M, Anders J, Xie B, Singh B, Ossandon M, Johnson M, Dickson RB, Lin CY.

Am J Pathol. 2001 Apr;158(4):1301-11.

PMID:
11290548
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Regulation of the matriptase-prostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 during epidermal differentiation.

Chen YW, Wang JK, Chou FP, Chen CY, Rorke EA, Chen LM, Chai KX, Eckert RL, Johnson MD, Lin CY.

J Biol Chem. 2010 Oct 8;285(41):31755-62. doi: 10.1074/jbc.M110.150367. Epub 2010 Aug 9.

PMID:
20696767
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk